Generative AI tools were used by 24% of cancer patients and caregivers for cancer information, with university-level education strongly predicting usage (aOR 4.47; 95% CI 2.195-9.109; p<0.001).
Cross-Sectional (n=400)
No
What are the awareness, attitudes, and usage patterns of generative AI tools among cancer patients and caregivers?
Generative AI use among cancer patients and caregivers is moderate (24%) and driven by younger age and higher education, with a high rate of non-disclosure to physicians highlighting a need for clinical integration.
Effect estimate: aOR 4.47 (95% CI 2.195-9.109)
p-value: p=<0.001
1612 Background: Generative artificial intelligence (AI) tools offer novel avenues for patient support, yet data on their adoption in oncology remain limited. This study evaluated the awareness, attitudes, and usage patterns of these tools among cancer patients and caregivers to inform clinical integration. Methods: A descriptive, cross-sectional survey was conducted at a tertiary oncology center. Adult cancer patients and caregivers completed an anonymous, structured questionnaire assessing sociodemographics, digital literacy, AI usage patterns, and perceptions. Multivariate logistic regression identified independent predictors of AI use. Results: A total of 400 participants (68% patients, 32% caregivers; mean age 59 years) were included. While 75% were aware of AI chatbots, only 24% used them for cancer-related information. Multivariate analysis revealed that university-level education (adjusted odds ratio aOR = 4.47, p 55 years) 2.64 1.594 - 4.381 <0.001 Education level (University or higher vs. lower) 4.47 2.195 - 9.109 <0.001 Time since diagnosis (<1 year vs. ≥1 year) 2.16 1.289 - 3.625 0.003 Abbreviations: aOR, adjusted odds ratio; CI, confidence interval.
İsmayılov et al. (Wed,) conducted a cross-sectional in Cancer (n=400). Generative AI tools was evaluated on Generative AI use for cancer-related information (aOR 4.47, 95% CI 2.195-9.109, p=<0.001). Generative AI tools were used by 24% of cancer patients and caregivers for cancer information, with university-level education strongly predicting usage (aOR 4.47; 95% CI 2.195-9.109; p<0.001).